Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need.
Investors 3
| Date | Name | Website |
| - | Biovision ... | biovision.... |
| 09.02.2024 | Red Tree V... | redtreevc.... |
| 27.01.2024 | Hadean Ven... | hadeanvent... |
Mentions in press and media 1
| Date | Title | Description |
| 04.04.2024 | Contineum Therapeutics Announces Pricing of Initial Public Offering | - |